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Abstract: - Every year, millions of people are suffering from bone defect arising from trauma, tumor or bone diseases. 
Therefore, there is a growing need for the development of biocomposites with excellent bioactivity and compatibility. 
In this study, nano-hydroxyapatite was elaborated by using polyvinyl alcohol (PVA) and polyvinylpyrrolidone (PVP) 
under mild temperature condition. Comparison with pure nano-hydroxyapatite prepared by precipitation method was 
investigated. The main goal is to highlight the effects of the introduction of polymers on the physico-chemical 
properties, morphology and on the chemical reactivity and bioactivity for applications in bony surgery. TEM showed a 
nanosphere hydroxyapatite with an average diameter 45 nm obtained by using PVA. Nano-rods HA with an average 
dimensions 13 nm width and 156 nm length were obtained by using, PVP. “In-vitro” physiological stability and 
solubility of the investigated samples was performed by soaking powder in Simulated Body Fluid under physiological 
condition. Characterization by XRD, FT-IR SEM-EDS and ICP-OES were performed to identify phases, 
microstructure and then the chemical reactivity and bioactivity after soaking in SBF to evaluate the bioactivity kinetics. 
Crystals on the polymer fibril matrix exhibited certain orientation. Bone like apatite layer onto the surfaces is 
confirmed after post immersion in SBF by FT-IR, SEM-EDS and XRD. The polymer matrix controlled the dissolution 
precipitation reactivity with specific rate without change on the pH of the surrounding physiological body fluid.  
 
Key-words: - Nano-Hydroxyapatite, bioactivity, biomimetic, polyvinyl alcohol, polyvinylpyrrolidone, Precipitation, 
Polymer matix composite, “in vitro” assay 
 
1 Introduction 
Bone repair or regeneration is a common and 
complicated clinical problem in orthopaedic surgery. 
Recently, a great deal of interest has been directed 
towards creating bioactive ceramic/polymer composites 
to be used as bone grafting materials. It is well known 
that natural bone is an inorganic/organic composite 
material. Hydroxyapatite (HA) is the main inorganic part 
in the bone composition and has been used as popular 
implant materials in the field of bone surgery [1]. There 
is no single existing material possesses all the necessary 
properties required in an ideal bone graft. Therefore,  
there is a growing interest in composite materials. As 
reported by previous authors, mixture of HA with 
polymer has been found to be an  effective formulation 
technology to gain the intelligent artificial bone 
materials [2-4]. 
Extensive efforts have been made to produce synthetic 
nano-HA materials. Methods that have been used for 
preparing nano-HA materials included chemical 
precipitation [5], sol-gel approach [6], microemulsion 
[7] and mechanochemical synthesis [8]. while, the 
biomimetic approach to produce HA powder has the 
challenge to endues the desired characteristics such as 
for example high specific surface area, fine grain size 
and monodisperse size distribution with very limited 
agglomeration [9]. Such characterization are directly 
depended on the process performed. Due to its simple 
process ; the wet-chemical precipitation route appears as 
the most talented way for HA powder  preparation. 
Whereas, when HA is used in composite form (HA-
polymer) it retains useful bioactive properties as well as 
enhancement of mechanical properties while showing 
acceptable osteoconductive properties. Therefore, the 
essence of the biomimicking process lies in mimicking 
biological mineralization with organic phase acting as a 
template for inorganic crystals. This can be used to help 
in nucleation and growth from supersaturated solution 
[10].  
Several Authors have investigated equivalent materials 
and the more recent attempts have used polymer 
additives such as poly(lactic acid) (PLA), poly(acrylic 
acid) (PAAc), collagen, and gelatin due to the efficiency 
of contained calcium binding properties [11–14]. It has 
also been shown that the polar polyvinyl alcohol (PVA) 
and polyvinylpyrrolidone (PVP) have very interesting 
applications in the biomedical field [15-18]. In our 
previous work, we concluded that the effect of polymer 
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on HA crystal (forming hydrogen bond at earlier stage of 
reaction). Therefore, it worked on the crystal 
morphology but not on the phase composition of the 
product [18]. The purpose of the present work was 
focused on the investigation of the bioactivity of the 
previously prepared composites [18] made of nano-
HA/polyvinyl alcohol (HA/PVA) and nano-
HA/polyvinylpyrrolidone (HA/PVP) through “in vitro” 
test in (SBF) solutions. We aimed to compare the results 
obtained of both pure and composite systems. Evaluation 
of the kinetic rate of dissolution of the composites was 
calculated using the ICP-OES assay in combination with 
the physico-chemical characterizations. 
 
2 Materials and Methods 
 
 
2.1 Elaboration Process of Nano- hydroxyapatite 
Composites 
The “In situ” preparation of nano-hydroxyapatite n-HA 
has been carried out in the presence of two different 
types of polymers; polyvinyl alcohol (PVA) and 
polyvinylpyrrolidone (PVP). Chemicals used for this 
study are PVA (Loba Chemicals, India), PVP (Winlab, 
U.K), calcium chloride dihydrate (AR) ( Sisco Research 
Laboratories , India) and  di-ammonium hydrogen 
phosphate (LR) (Arabian Medical & Scientific Lab. Sup. 
Co, U.A.E) and sodium hydroxide. Nanohydroxyapatite, 
without polymer named here after as SHA has been 
prepared by precipitation [19] and was used for 
comparison. The composites of n-HA associated with 
PVA or PVP polymers were denoted as HAV or HAP, 
respectively [18]. The first step in the synthesis of the 
composites was the preparation of a 1.388 M calcium 
chloride dihydrate solution and a 0.833 M solution of di-
ammonium hydrogen phosphate (LR). The calcium 
chloride dihydrate solution was slowly added to the 
polymer solution under continuous stirring and heating 
for approximately 10 min at 60 oC. The pH of the 
solution was adjusted to 11 by sodium hydroxide. Then, 
di-ammonium hydrogen phosphate solution was added 
gradually to the above mixture. A milky white coloration 
was observed almost instantaneously after the addition 
of phosphate solution. The pH of the solution was 
adjusted and maintained at its initial value of pH 11. 
Then the temperature was rised up to 90 oC with constant 
stirring for 3 hours. The suspension was left to age at 
room temperature for 24 hrs. After decantation the 
solutions obtained in this manner was centrifugated at 
4500 rpm and washed with distilled water then dried in 
an oven at 60oC over a night. 
 
 2.2 Physico-chemical Characterization  
 The morphology and the size of the powder particles 
were examined under Transmission Electron Microscope 
(TEM). Therefore a solution made of a suspension of a 
few mg of the obtained powder in distilled water 
prepared then highly dispersed in ultrasonic bath for 15 
min. Few drops of the suspensions were put on 
previously prepared grids covered by a thin film of 
evaporated carbon. The grids were examined under TEM 
using a  Philips CM-20 equipment operated at 200 kv. 
Further physico-chemical characterizations have been 
made using Fourier Transformed Infra Red Spectroscopy 
(FTIR) (BRUKER EQUIPED 55) and X-Ray Diffraction 
(XRD) using (Inel Diffractometer). These experiments 
have been carried out before and after “in vitro” test. FT-
IR analysis spectra have been recorded on samples in the 
form of pellets using KBr as the standard.  
 
2.3 In vitro assays in SBF 
In vitro tests have been achieved after soaking 30 mg of 
powder into 60 ml of simulated body fluid (SBF) with 
mineral composition nearly equal to those of human 
blood plasma (Table 1), according to Kokubo’s protocol, 
at 37 oC in an incubator with shaking at 50 rpm [20]. 
After soaking in SBF during various ranges of time; 
short time of immersion (30 min, 9h., 12h. and 2 days) 
and longer time for (5, 7, 14 and 30 days), the powders 
were filtered, cleaned with deionized water to stop the 
reaction and then by ethanol. The drying was achieved in 
an oven at 60 oC over a night. The physico-chemical 
properties of the filtered powders were studied by FTIR, 
XRD, SEM Jeol with EDS. Inductively Coupled Plasma-
Optical Emission Spectroscopy (ICP-OES), type CIROS 
vision was employed to determine the ionic exchange 
between compound and SBF liquid. The ionic 
concentrations of Ca and P amounts in synthetic 
physiological liquid (SBF) and their release versus 
soaking time was highlighted. Also, the pH of SBF was 
monitored versus the same soaking period of time. 
 
Table 1: Concentrations of the SBF solution 
Inonic concentrations, 10-3 mol.L-1  
Na+    K+  Ca2+   Mg2+  Cl-    HCO3-  HPO42- 
SBF 142    5     2.5     1.5   148.8   4.2        1 
Plasma 142    5     2.5     1.5   103.0   27.0      1 
 
3 Results and Discussion 
Various artificial materials including medical polymer, 
bioceramics, metallic materials and their composites are 
currently in use for bone repairing. However, none of 
them can perform as perfectly as natural bone. 
Therefore, there is a real need for new biomaterials for 
bone defect repair. As a matter of facts, nano-
hydroxyapatite/ polyvinyl alcohol and 
polyvinylpyrrolidone composites; HA-PVA and HA-
PVP respectively have been studied in this objective [15-
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18]. Nevertheless, to our knowledge no report has 
already discussed the kinetic bioactivity and the 
chemical reactivity of such composites. Investigation of 
the biological behavior of these biomaterials in SBF is 
considered as one of the most efficient and economical 
way to predict their bioactivity in the physiological 
environment. The “in vitro” formation of an apatite layer 
on the surface of the materials in the SBF is used 
extensively for evaluating the bioactivity of bone 
substitute materials [21]. 
 
 3.1 Physico-chemical characterization before 
“in-vitro” experiment 
TEM micrographs given in (Fig. 1) show that the 
particles are aggregated as clusters in the pure sample of 
HA (without polymer) prepared by precipitation (SHA).  
 
  a- SHA                                  b- HAV  




  c- HAP                                  d- HAP  
    
 
 
Fig.1, TEM micrographs of the prepared nano-
hydroxyapatite samples: (a): without polymer (SHA), 
(b): hydroxyapatite composite HAV and (c, d): 
hydroxyapatite composite HAP 
 
They  appear as tiny plate grains, which tend to 
segregate together with a cross section of about  80.3 nm 
(Fig. 1-a). It has been shown that on using polymer 
matrix in composite samples of  HA-PVA (HAV) and 
HA-PVP (HAP) such agglomeration has nearly 
disappeared. The composite  sample HAV seemed to be 
nearly elongated in shape with smaller particle size than 
SHA as shown in (Fig. 1-b). While, HAP (Figure 1-c, d) 
appears like fibers or rod like particles with at least 100 
nm in length and about 10-20 nm in diameter. Platy 
shaped grains occurring as bundles are shown in (Fig. 1-
d). Therefore it appears  that the PVP polymer greatly 
facilitated the formation of rodlike HA crystals which 
preferentially tend to grow along the <001> direction as 
described by Zhang and Lu [16].  
The ICP-OES technique was employed to determine the 
amounts of Ca and P in the prepared samples before 
immersion in SBF liquid. Data are presented in our 
previous work [18]. These data show that the molar 
(Ca/P) ratio of pure stochiometric hydroxyapatite SHA 
equal to1.70. Furthermore, the addition of polymer in the 
composite samples HAV and HAP was found to increase 
this ratio up to 1.85 near that of biological apatite [19]. 
Where, bone-apatite is characterized by molar Ca/P ratio 
varying from 1.37 to 1.87. Therefore, the internal crystal 
disorder and ionic substitution within the apatite lattice 
results in the presence of significant levels of additional 
trace elements within bone mineral [22, 23].  Then,  this 
plays great roles in the overall performance of human 
bones [24]. 
 
  3.2 Bone-like apatite structure characterization 
  
There is a great challenge to characterize the newly-
formed bone-like apatite on the calcium phosphates with 
FT-IR spectroscopy, XRD analysis and SEM-EDS 
composition analysis due to the structure and 
composition similarities of the newly-formed layer and 
the CaP substrates.  
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Fig.2, FTIR of the prepared nanohydroxyapatite samples 
a) without polymer SHA, b) hydroxyapatite composite 
HAV, c) hydroxyapatite composite HAP; before and 
after immersion in SBF at 14 days and 30 days 
Figs 2-a, b and c show typical FT-IR spectra recorded 
for the samples SHA, HAV and HAP before and after 
immersion during 14 and 30 days, respectively. Before 
immersion all samples present the disordered character 
(broad bands) related to the nanocrystalline size of HA 
[25]. All samples showed bands of carbonate (around 
1417 and 1456 cm-1) and of phosphate (stretching 
vibration: 1070, 1020, 980 and 930 Cm-1), (bending: 
725, 605, 560 and 490 Cm-1) in the region  at (500-1050 
Cm-1) [26]. The presence of carbonate inclusions might 
have come from air carbon dioxide taken during process 
from air [25]. The region below 1000 cm-1 can be 
interpreted according to the attribution given by Rey et 
al [27]. The band at 570 cm-1 is due to apatitic 
phosphate, PO43-. This peak was resolved that assigned 
to PO4 and HPO4 2-. This is in agreement with the results 
of Jager et al [25] that confirmed through NMR 
investigation that the nanocrystals consist of a crystalline 
hydroxyapatite core covered by a disordered surface 
layer of HPO4 2-. Other bands of carbonate appeared at 
868 cm-1. In the spectrum of HAP sample (Figure 2-c) 
before immersion there is a new band at 1250 cm-1 
attributed to polyvinylpyrrolidone polymer. Its effect has 
been also shown in the bands localized at nearly 1400 
cm-1 and 1600 cm-1.  Urch et al [28] referred to the peak 
presented at 1659 cm-1 to the presence of polymer PVP 
but here we referred this peak to that of carbonate as it is 
presented in all samples even that without polymer 
maybe overlapping with it. There is a change in the O.D. 
of the phosphate groups assigned before  and also the 
OH group near 3500 cm-1 after immersion for 14 as well 
as 30 days. This is clearly appeared  for samples SHA 
and HAV (Fig. 2 a and b) compared to that before 
immersion. This proves the effect of immersion and their 
involvement in the biolayer formation. Fig. 2c of sample 
HAP shows that the O.D. of phosphate groups and OH 
groups overlapping with the polymer bands. They are 
enhanced after immersion compared to that before 
immersion. This proves the deposition of some ions from 
the SBF onto the surface of powder of HAP. This is 
happened as a result of interaction between PVP via 
imide group N-C=O and the phosphate ions in SBF. In 
addition, the O.D. of these bands is slightly increased 
denoting the presence of PVP polymer that hydrolyzes to 
form carboxyl group resulting in apatite nucleation [29]. 
Therefore, the introduction of polymer create more 
adhesion with physiological liquid and consequently 
enhance the bioactivity of the composite. These 
important results showed that this stage characterize the 
direct consequence of the interaction and binding 
between the orderly arranged side groups like N-C=O 
characteristic of the PVP polymer and the nucleating HA 
nanocrystals. 
 
Fig. 3 shows XRD patterns of investigated samples 
before and after immersion in SBF. There are differences 
in intensity of the peaks for the spectra before and after 
immersion as it is referred to the structure of apatite. 
Special refinement of the peaks observed in the spectrum 
after 30 days of immersion highly imperfect apatite 
particles formed on the surface in SBF.  
 





















Figure 3: XRD of the prepared nano-hydroxyapatite 
samples, a) without polymer SHA b) hydroxyapatite 
composite HAV, c) hydroxyapatite composite HAP; 
before and after immersion in SBF at 30 days 
 
 




Fig.4, SEM of (a) pure hydroxyapatite SHA, (b) 
hydroxyapatite-polyvinyl alcohol polymer matrix HAV 
and (c) hydroxyapatite-polyvinylpyrrollidone HAP;  
after 30 days of immersion in SBF with different 
magnifications 
The SEM micrographs coupled with EDS of samples of 
pure-HA (SHA), HA-polyvinyl alcohol (HAV) and HA-
polyvinlpyrrolidone (HAP) after 30 days of immersion 
in SBF, with different magnifications are presented in 
Fig. 4 and 5. More precisely Fig. 4-a shows the coli 
flower precipitation of hydroxyapatite on its higher 
magnification showed very fine nature of 
nanohydroxyapatite precipitation layer. For both 
composites HAV and HAP the SEM figures show 
significant differences between pure SHA and that of the 
composites samples. Incorporation of HA with  these 
polymers induce a great modification of their grains. 
There are presented in a particular geometrical form 
elongated needle shaped of about 500 nm. The scanning 
electron microscopy analysis suggests the existence of 
strong molecular interaction between each type of 
polymers PVA and PVP networks, leading HA to be 
dispersed uniformly in the composite. EDS spectra (Fig. 
5) showed the presence of Ca, P, Na and Cl in all 
samples. The phosphocalcic ratio Ca/P after 30 days of 
immersion in SBF (examination over the whole surface) 
is nearly equal to the stoichiometric apatite as it is equal 
to 1.73, 1.78 and 1.79 for SHA, HAV and HAP, 
respectively. This explains the formation of bone like 
apatite. The results obtained from XRD and SEM 
coupled with EDS are complementary and confirmed 
that the  layer formed over the pure nano-HA or over 
nano-HA/polymer composite are bone like apatite 







Fig.5, EDS elemental analysis of (a) pure hydroxyapatite 
SHA, (b) hydroxyapatite-polyvinyl alcohol polymer 
matrix HAV and (c) hydroxyapatite-
polyvinylpyrrolidone HAP; after 30 days of immersion 
in SBF. 
3.3 Bioactivity test 
To evaluate the ionic exchanges and then the chemical 
reactivity of our investigated samples SHA, HAV and 
HAP, the synthetic physiological liquid (SBF) was 
systematically analyzed after the withdrawal of powder 
samples. Different delays of soaking ; short time 
intervals (30 min, 9 hrs, 12 hrs and 2 days) and long time 
intervals (5 days, 7 days, 14 days and 30 days) were 
chosen. Ionic exchange between pure 
nanohydroxyapatite SHA and composite samples HAV 




Fig.6, Evolution of elemental concentrations of Ca in 
SBF measured by ICP, Versus soaking time 
 




Fig.7, Evolution of elemental concentrations P in SBF 
measured by ICP, Versus soaking time. 
 
The variation of calcium and phosphorous ionic 
concentration in the SBF liquid are presented in (Figs. 6 
and 7), respectively. A magnification of the short period 
soaking times of each element up to 5 days (120 h) is 
also presented. ICP-OES results highlight different 
behaviors of the three calcium phosphate samples. The 
behavior of change in the Ca and P concentrations could 
be divided into three stages ; first stage accompanies by 
a decrease, second stage accompanies by a stop or slight 
increase and the third stage accompanies by a continuous 
decrease again till 30 days of both elements. These 
stages have a significant differences between pure HA 
(SHA) sample and that of the composites HAV and 
HAP. For SHA sample ; the 1st stage accompanies by a 
decrease in Ca and P concentration is extended up to 5 
days (120 h) then the 2nd stage accompanies by slight 
increase from 5-7 days (120-168 h) and lately the 3rd 
stage accompanies by continuous decrease again starts 
from 7-30 days (168-720h). For composite HAV sample 
the 1st stage accompanies by a decrease in Ca and P 
concentration happens in the early stage of immersion 
only up to 12 h then the 2nd stage starts and accompanies 
by slight increase  up to 7 days (12-168h) and lately the 
3rd stage accompanies by continuous decrease again 
starts from 7-30 days (168-720h).  Besides, HAP 
composite sample attain the same behavior as HAV with 
a slight change in the 1st stage that it is extended up to 2 
days (48h) more than 12h in case of HAV. In addition, 
there is a stability in the second stage without realising 
an increase The decrease in pure HA (SHA) is much 
more evident in the beginning than that in case of 
polymer composites (HAV and HAP). But, after 30 days 
all samples reached almost to the same point of 
consumption for  Ca and P from SBF. This means that 
the presence of polymer enhances the bioactivity in the 
early stages and their involvement in the biolayer 
formation due to the effect of mineralization. We can 
conclude that the first stage is accompanied by 
consuming Ca and P ions from SBF then the second 
stage was accompanied by equilibrium of the exchange 
of ions with solution before the last stage that 
accompanied by these exchange again. These three 
stages are variables in the three investigated samples 
these apparently due to the presence of polymer. This 
could be explained by the rapid saturation of polymer 
composite HAV and HAP samples network. This means 
that the equilibrium stage is enhanced in the presence of 
polymer better than pure HA. So, the chemical 
composition of SBF is less altered in contact with both 
the composites samples than the pure-HA sample. This 
is an important effect and advantageous of the composite 
samples of hydroxyaptite HAV and HAP as they haven’t 
altered the chemical properties of the surrounding 
physiological liquid for a long time like in case of pure-
HA. This may lead to less inflammation when use in 
surgery. 
We can also calculate the amount of Ca and P consumed 
from SBF and precipitated on the samples surface after 
30 days of immersion. Data are shown in Table 2. From 
these data we can calculate the phosphocalcic ratio. 
These ratios are 1.72, 1.63 and 1.66 for SHA, HAV and 
HAP respectively. This is in a good agreement with the 
EDS analysis. It is evident that the consumption of both  
Ca and P amounts after 30 days is nearly the same for all 
the investigated samples  leading to the formation of 
stoichiometric hydroxyapatite. These results  are also 
confirmed by measuring the pH of the SBF at the same 
previous time intervals of soaking (Fig. 8). We can 
notice that the use of composites with polymer matrix of 
either PVA or PVP did not show a drop in pH upon “in 
vitro” degradation on immersion in SBF as described by 
Tadic el al. [30].   
The induction of apatite formation on the surface maybe 
resulted from the dissolution of nano-HA which may 
lead to the local supersaturation of Ca 2+ and PO4 3-and 
may promote the nucleation and growth of apatite 
crystals. Moreover, the presence of negatively charged 
carboxylate groups of polyvinylpyrrolidone or OH 
groups in polyvinyl alcohol surface may attract calcium 
ions present in the SBF solution and favor calcium 
phosphate apatite nucleation. Once the apatite nuclei 
formed, they can grow spontaneously by consuming the 
calcium and phosphate ions from the surrounding SBF. 
Substitution of CO3 2- ion in the SBF for the PO4 3- ion in 
the apatite results in the Ca/P atomic ratio of the apatite 
increases. This property can probably be extended to 
other bioactive ions. Nanocrystalline apatites can adsorb 
much larger amounts of bioactive molecules and proteins 
than well crystallized apatites for the same surface area 
[31].  
The detonation of nano-hydroxyapatite polymer 
composite surface is chemically multifunctional (surface 
OH, COOH, C=C, C-O-C and C=O groups exist), so that 
the hydroxyapatite is grown both by physical adsorption 
and chemical interaction. These groups are regarded to 
play an important role in the hydroxyapatite growth on a 
composite surface from SBF. 





The present work has demonstrated the possibility to 
prepare nano-hydroxyapatite associated with polyvinyl 
alcohol and polyvinylpyrrolidone polymer composites. 
The method used is a simple and reproducible 
biomimetic approach at low temperature. The two types 
of polymer charge HA negatively and attract Ca 2+ ions, 
which in turn attract PO4 3- ions, thus forming apatite 
nuclei. Considerable efforts have been made to control 
the shape of the nanocrystals during synthesis owing to 
their shape-dependent properties. However, generally 
capping agents/surfactants that preferentially adsorb on 
different crystal surfaces are used to achieve such shape 
control [32]. By this approach, some of the demerits of 
nano HA such as bioresorption and particle migration 
can be alleviated. The rate of bioresorption of nano HA 
was controlled and improved by the addition of both 
types of polymer PVA and PVP. Equilibrium stage starts 
early in both composite samples might be leading to 
minimize the effect of inflammation after surgery. It is 
anticipated that this kind of composites would act as a 
bone substitute with superior bioactivity and 
osteoconductivity when they are applied in bony surgery 
and particularly as bony substitute materials. The above 
findings pave ways to exploit the use of the investigated 
composites into bone tissue engineering. 
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